Medicamen Biotech informs about compliances certificate

18 Apr 2022 Evaluate

Medicamen Biotech has informed that it enclosed a certificate dated April 12, 2022 obtained from AMJ & Associates, Practicing Company Secretaries for the year ended March 31, 2022, pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

301.30 -3.55 (-1.16%)
25-Feb-2026 12:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1763.40
Dr. Reddys Lab 1318.00
Cipla 1340.00
Zydus Lifesciences 915.55
Lupin 2292.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×